Developing Regenerative Medical Products to Treat Injuries and Inflammatory Diseases
Passionate - Innovative - Hardworking
Core principles we live and work by.
We’re AKAN Biosciences
A biotechnology and cellular therapy company developing next-generation injectable products to treat degenerative diseases and injuries. We’re developing cellular therapies and proprietary manufacturing methods to produce stem cell-based therapeutics using state-of-the-art tissue engineering and cell-based approaches to treat degenerative diseases and injury. Our uniquely well-suited team has substantial clinical experience with stem cell therapies and various relevant indications.
We believe in improving people’s lives and curing hard-to-treat diseases.
Our patients are our purpose and driving force. We put all our efforts and resources into creating safe and effective treatments for patients.
Our innovative team is committed to creating adipose stem cell products to improve patients’ lives.
We're an innovator in supplying quality non-expanded adult stem cell-based products and therapies for homologous and non-homologous uses to healthcare providers.
We’ve created several tissue-based products
Our products repair, reconstruct and replace skin tissue for homologous application in human recipients.
Our product, StroMel™, is currently in Phase 2 clinical trial for osteoarthritis (OA) of the knee. Additional trials are planned in other indications later this year for OA for other joints, wound healing, crohn’s disease, sports injuries, and autism.
Our Motivation
Our ultimate goal is to make stem cell-based anti-inflammatory, regenerative, and reparative products accessible and available to anyone who needs it.
AKAN Biosciences
Passion. Innovative. Hardworking
Contact us for more information about programs, products and services